Compare SSB & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SSB | CRL |
|---|---|---|
| Founded | 1933 | 1947 |
| Country | United States | United States |
| Employees | 6190 | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 7.5B |
| IPO Year | 2008 | 1999 |
| Metric | SSB | CRL |
|---|---|---|
| Price | $89.61 | $158.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $118.92 | ★ $197.58 |
| AVG Volume (30 Days) | ★ 783.0K | 746.5K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | ★ 12.91 | N/A |
| EPS | ★ 7.87 | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $9.87 | $0.99 |
| Revenue Next Year | $6.37 | $3.26 |
| P/E Ratio | $11.68 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $77.74 | $91.86 |
| 52 Week High | $108.46 | $228.88 |
| Indicator | SSB | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 34.76 | 43.22 |
| Support Level | $85.01 | $158.36 |
| Resistance Level | $91.24 | $166.62 |
| Average True Range (ATR) | 2.06 | 6.79 |
| MACD | 0.17 | 1.37 |
| Stochastic Oscillator | 26.14 | 42.54 |
SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time, and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.